Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway
Wen Li, Shaohua Tao, Fan Guo, Ling-Zhi Li, Hongliu Yang, Yan Liang, Lidan Zhang, Liang Ma, Ping Fu
Topics & Concepts
EZH2CisplatinDownregulation and upregulationAcute kidney injuryHistone H3KidneyCancer researchInflammationGene silencingPharmacologyChemistryHistone methyltransferaseApoptosisHistoneMedicineEndocrinologyImmunologyInternal medicineBiochemistryGeneChemotherapyChemotherapy-induced organ toxicity mitigationAcute Lymphoblastic Leukemia researchPalliative Care and End-of-Life Issues